Skip to main content

Table 1 Characteristics of Patients with Diabetes Presenting to a Retina Clinic

From: Identification of population characteristics through implementation of the Comprehensive Diabetic Retinopathy Program

 

Entire cohort

Subsample: risk score 2

N = 2916

N = 1014

N or Mean

% or SD

Min

Max

N or Mean

% or SD

Min

Max

Patient age Mean (SD)

64.05

14.29

13

99

62.79

13.89

17

98

Race N(%)

 Asian

134

4.60

  

39

3.85

  

 Black, African American

431

14.78

  

198

19.53

  

 White or Caucasian

2171

74.45

  

715

70.51

  

 Unknown/other/mixed

180

6.17

  

62

6.11

  

Sex N(%)

 Female

1365

46.81

  

467

46.06

  

 Male

1551

53.19

  

547

53.94

  

Ever smoked N (%)

 Yes

1287

44.14

  

415

40.93

  

 No/unknown

1629

55.86

  

599

59.07

  

Diabetic retinopathy N (%)

 Yes

1664

57.06

  

806

79.49

  

 No

1252

42.94

  

208

20.51

  

Diabetes type N(%)

 Type 1

356

12.21

  

143

14.10

  

 Type 2

1883

64.57

  

736

72.58

  

 Undefined

677

23.22

  

135

13.31

  

Maximum microalbumin N(%)

  < 30

239

8.20

  

96

9.47

  

30

186

6.38

  

159

15.68

  

 Unknown

2491

85.43

  

759

74.85

  

History of kidney diagnosis N(%)

 Yes

509

17.46

  

436

43.00

  

 No/unknown

2407

82.54

  

578

57.00

  

Duration of diabetes 10 years

 Yes

1404

48.15

  

885

87.28

  

 No

1512

51.85

  

129

12.72

  

Max patient’s BMI Mean (SD

33.46

7.96

17

81

34.02

8.39

17

81

Maximum systolic blood pressure Mean (SD)

141.91

22.86

80

237

152.71

22.7

87

237

Maximum diastolic blood pressure Mean (SD)

73.73

11.53

40

123

77.19

11.83

42

118

Maximum HbA1c Mean (SD)

8.01

1.80

4.30

15.70

8.68

2.01

4.70

15.70

Patient’s number of visits Mean (SD)a

3.91

3.70

1

27

4.85

4.11

1

25

  1. aFor the number of visits outcome a subcohort of patients who presented with at least 12 months of potential follow up has been evaluated (N = 1504 for the whole cohort; N = 634 for the subgroup of patients with risk score ≥ 2)